21
Sep
2024
00:00
BST
Webinar
20
Sep
2024
19:00
EDT
16:00
PDT
Test Webinar Authors
00
Days
00
Hours
00
Mins
00
Secs
![](https://assets.radcliffe-group-non-prod.com/s3fs-public/webinar/2023-08/Screenshot%202023-08-22%20at%2013.11.41%20%281%29.jpg)
Faculty:
![Nicolas M Van Mieghem](https://assets.radcliffe-group-non-prod.com/s3fs-public/author/2020-12/NMDAvanM.jpg)
Nicolas M Van Mieghem
Joost Daemen
![Roxana Mehran](https://assets.radcliffe-group-non-prod.com/s3fs-public/author/2020-12/RoxanaM.jpg)
Roxana Mehran
Overview
Access the slide kit, webcast, and report of the ESC hotline presentation:
http://congress365.escardio.org/Acute-Coronary-Syndrome?vgnextkeyword=Mo...
Support test Support test Support test
![Sponsor](https://assets.radcliffe-group-non-prod.com/s3fs-public/webinar-sponsor/2023-01/radcliffe-me-horizontal.png)
Agenda
Objective title
Objective header
- List objective item 1
- List objective item 2
Target audience title 1
Target audience header 1
- List item 1
- List item 2
- List item 3
Faculty Biographies
![Nicolas M Van Mieghem](https://assets.radcliffe-group-non-prod.com/s3fs-public/author/2020-12/NMDAvanM.jpg)
Nicolas M Van Mieghem
Dr Nicolas M Van Mieghem obtained his medical degree and cardiology degree at the Catholic University of Leuven, Belgium. After subsequent fellowships in interventional cardiology in Ziekenhuis Oost-Limburg Genk, Belgium, Lenox Hill Hospital, New York, US and Erasmus Medical Center, Rotterdam, the Netherlands, he joined the department of interventional cardiology at the Thoraxcenter, Erasmus Medical Center, as a senior staff member in February 2010.
He is involved in the percutaneous coronary interventions and structural heart program. He obtained the degree of PhD based upon his research in transcatheter valve therapies. So far he has published and co-authored approximately 130 scientific papers in peer-reviewed journals.
Dr Van Mieghem is principle investigator and steering committee member in multiple ongoing international trials evaluating various coronary and transcatheter valve technologies. He is a Fellow of the European Society of Cardiology and is currently Medical Director of the department of Interventional cardiology at the Thoraxcenter.
![Roxana Mehran](https://assets.radcliffe-group-non-prod.com/s3fs-public/author/2020-12/RoxanaM.jpg)
Roxana Mehran
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, FSCAI is Professor of Medicine and Director of Interventional Cardiovascular Research and Clinical Trials at the Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai School of Medicine.
Dr. Mehran is currently Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A. Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past five years, she has led the development of a globally-respected data and clinical coordination center to support large, multicenter, multinational clinical trials designed, by her team, to help clinicians improve outcomes and quality of life for patients undergoing interventional cardiovascular procedures. In recent years, her work has had a special emphasis on gaining a deeper understanding of anticoagulation and antiplatelet regimens post angioplasty and transcatheter valve replacement; and collection and interpretation of sex-specific data in cardiovascular clinical trials.
Dr. Mehran serves on editorial board of multiple peer reviewed journals, including Journal of the American College of Cardiology, Circulation, and Circulation Research. She currently serves on the board of trustees of SCAI, as a member of the Program Committee for the American Heart Association Scientific Sessions, as a member of the board of directors for Harboring Hearts, and as Program Chair for Society of Cardiac Angiography and Interventions (SCAI- WIN (Women in Innovations)) Initiative, and is also the Chief Scientific Officer of the Clinical Trials Center at the Cardiovascular Research Foundation (NYC).
Joost Daemen
Dr Joost Daemen, MD, PhD obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of 4 trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.
Key References
1. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque iaculis nibh non massa vulputate, pretium feugiat nisi molestie. Aenean in libero a turpis dapibus egestas id efficitur mi. Nam dignissim orci et diam cursus, nec feugiat risus hendrerit. Donec tincidunt mi libero, id tempus nunc blandit tempor. Nunc nisl lectus, dictum id tortor in, vulputate semper odio. Aliquam quis porttitor leo. Cras accumsan risus risus, quis fringilla erat sagittis quis. Sed blandit urna sit amet gravida eleifend. Etiam eget leo vitae turpis porta scelerisque.
Aenean in dui auctor, aliquam mauris quis, mattis leo. Duis ut mollis justo, vel facilisis tortor. Mauris et dictum nibh. Maecenas feugiat lorem ac libero convallis, sed pharetra eros malesuada. Proin ac aliquet turpis. Aliquam posuere ipsum in odio egestas maximus. Cras dui est, facilisis sit amet mauris eget, maximus venenatis metus.
2. Reference 2
3. Reference 3